Original Biomedicals Co Ltd

NEW
ROCO:6483 (Taiwan)  
NT$ 13.15 (0%) Jul 13
At Loss
P/B:
5.65
Market Cap:
NT$ 892.29M ($ 27.80M)
Enterprise V:
NT$ 759.65M ($ 23.67M)
Volume:
95.43K
Avg Vol (2M):
102.37K
Trade In:
Volume:
95.43K
At Loss
Avg Vol (2M):
102.37K

Business Description

Description
Original Biomedicals Co Ltd is a biopharmaceutical company engaged in the research and development of drugs. The company focuses on developing new drug formulations, drug delivery systems, and repurposing existing pharmaceutical products.
Name Current Vs Industry Vs History
Cash-To-Debt
12.85
Equity-to-Asset
0.86
Debt-to-Equity
0.07
Debt-to-EBITDA
-0.12
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
15.79
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
46.62
9-Day RSI
51.09
14-Day RSI
50.93
3-1 Month Momentum %
-16.77
6-1 Month Momentum %
-5.49
12-1 Month Momentum %
5.74

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
9.74
Quick Ratio
9.74
Cash Ratio
8.54
Days Sales Outstanding
191.6

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-12.3
Shareholder Yield %
-0.15

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin %
80.32
Operating Margin %
-27453.02
Net Margin %
-26643.05
EBITDA Margin %
-24169.82
FCF Margin %
-25448.29
OCF Margin %
-25199.21
ROE %
-48.85
ROA %
-43.7
ROIC %
-387.37
3-Year ROIIC %
428.72
ROC (Joel Greenblatt) %
-402.77
ROCE %
-46.6

Financials

ROCO:6483's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Original Biomedicals Co Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil NT$) 0.381
EPS (TTM) (NT$) -1.53
Beta -0.1811
3-Year Sharpe Ratio -0.04
3-Year Sortino Ratio -0.06
Volatility % 55.96
14-Day RSI 50.93
14-Day ATR (NT$) 0.611778
20-Day SMA (NT$) 13.0525
12-1 Month Momentum % 5.74
52-Week Range (NT$) 9.12 - 20
Shares Outstanding (Mil) 66.59

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Original Biomedicals Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Original Biomedicals Co Ltd Stock Events

Financials Calendars
Event Date Price (NT$)
No Event Data

Original Biomedicals Co Ltd Frequently Asked Questions

What is Original Biomedicals Co Ltd(ROCO:6483)'s stock price today?
The current price of ROCO:6483 is NT$13.15. The 52 week high of ROCO:6483 is NT$20.00 and 52 week low is NT$9.12.
When is next earnings date of Original Biomedicals Co Ltd(ROCO:6483)?
The next earnings date of Original Biomedicals Co Ltd(ROCO:6483) is .
Does Original Biomedicals Co Ltd(ROCO:6483) pay dividends? If so, how much?
Original Biomedicals Co Ltd(ROCO:6483) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Original Biomedicals Co Ltd

No articles.